88 related articles for article (PubMed ID: 21110340)
1. Synthesis and in-vitro inotropic evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-phenyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides.
Jiang SM; Ye BJ; Liu XK; Zhang TY; Cui X; Piao HR
Arch Pharm (Weinheim); 2010 Nov; 343(11-12):700-5. PubMed ID: 21110340
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and positive inotropic evaluation of 2-(4-(4-substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl[1,2,4]triazolo[4,3-a]quinolin-7-yl)-acetamides.
Li JY; Cui X; Liu XK; Hong L; Quan ZS; Piao HR
Arch Pharm (Weinheim); 2008 Dec; 341(12):794-9. PubMed ID: 19006092
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2-(4-substitutedbenzyl-[1,4]diazepan-1-yl)-n-(1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides as inotropic agents.
Ye BJ; Liu XK; Jiang SM; Cui X; Piao HR
Chem Biol Drug Des; 2011 Jan; 77(1):98-103. PubMed ID: 21114630
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and positive inotropic activity of N-(4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(piperazin-1-yl)acetamide derivatives.
Zhang CB; Cui X; Hong L; Quan ZS; Piao HR
Bioorg Med Chem Lett; 2008 Aug; 18(16):4606-9. PubMed ID: 18657421
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and positive inotropic evaluation of (E)-2-(4-cinnamylpiperazin-1-yl)-N-(1-substituted-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides.
Wu Y; Ma LX; Niu TW; Meng FL; Cui X; Piao HR
Arch Pharm (Weinheim); 2012 Dec; 345(12):980-8. PubMed ID: 23015381
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2-(4-substituted benzyl-1,4-diazepan-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
Yang K; Sun LP; Liu JY; Cui X; Piao HR
Bioorg Med Chem Lett; 2010 Aug; 20(15):4464-7. PubMed ID: 20591664
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and positive inotropic evaluation of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides bearing piperazine and 1,4-diazepane moieties.
Wu Y; Ma LX; Niu TW; Cui X; Piao HR
Bioorg Med Chem Lett; 2012 Jul; 22(13):4229-32. PubMed ID: 22672796
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
Liu XK; Cui X; Hong L; Sun LP; Quan ZS; Piao HR
Eur J Med Chem; 2009 Jul; 44(7):3027-31. PubMed ID: 18824278
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and inotropic evaluation of 1-substituted-N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)piperidine-4-carboxamides.
Liu JY; Yu HL; Quan ZS; Cui X; Piao HR
Bioorg Med Chem Lett; 2009 May; 19(9):2392-5. PubMed ID: 19356931
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-(4-substitutedbenzylpiperazin-1-yl)-N-(2-oxo-2,3-dihydrobenzooxazol-6-yl)acetamides as inotropic agents.
Zhang T; Sun L; Liu X; Cui X; Piao H
Med Chem; 2012 Nov; 8(6):1093-8. PubMed ID: 22779804
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new triazole acetamides with inotropic effects.
Wu Y; Ma LX; Sun LP; Song MX; Cui X; Piao HR
Bioorg Med Chem Lett; 2013 Feb; 23(3):757-60. PubMed ID: 23265872
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Positive Inotropic Activity of [1,2,4]Triazolo[4,3-a] Quinoxaline Derivatives Bearing Substituted Benzylpiperazine and Benzoylpiperazine Moieties.
Liu XK; Ma LX; Wei ZY; Cui X; Zhan S; Yin XM; Piao HR
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208674
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agents.
Wu Y; Sun LP; Ma LX; Che J; Song MX; Cui X; Piao HR
Chem Biol Drug Des; 2013 May; 81(5):591-9. PubMed ID: 23279930
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and positive inotropic evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted piperazine moieties.
Ma LX; Cui BR; Wu Y; Liu JC; Cui X; Liu LP; Piao HR
Bioorg Med Chem Lett; 2014 Apr; 24(7):1737-41. PubMed ID: 24636107
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and negative inotropic effects evaluation of 7-substituted-4,5-dihydro-[1,2,4]oxadiazolo[4,3-a]quinolin-1-ones.
Hong L; Gong GH; Yu L; Song MX; Cui X; Quan ZS
Arch Pharm Res; 2013 Nov; 36(11):1338-44. PubMed ID: 23918646
[TBL] [Abstract][Full Text] [Related]
16. The progress towards the development of DHQO derivatives and related analogues with inotropic effects.
Wu Y; Piao HR
Mini Rev Med Chem; 2013 Oct; 13(12):1801-11. PubMed ID: 24032511
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines.
Sun XY; Wei CX; Chai KY; Piao HR; Quan ZS
Arch Pharm (Weinheim); 2008 May; 341(5):288-93. PubMed ID: 18389515
[TBL] [Abstract][Full Text] [Related]
19. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
[TBL] [Abstract][Full Text] [Related]
20. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
